IO Biotech Company
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Funding Status:
IPO
Total Funding:
175012360
Last Funding Type:
Series C
Industry:
Peptides and Proteins
Estimated Revenue:
$1M to $10M
Founded Date:
2014-12-23
Last Funding Date:
2021-10-07
Headquarters:
Copenhagen, Hovedstaden, Denmark
Employee Number:
11-50
Investors Number:
16